Literature DB >> 15932801

Gene targeting with viral vectors.

Paul C Hendrie1, David W Russell.   

Abstract

Genetic manipulation of cells for scientific and therapeutic goals can be achieved by both gene-addition and gene-targeting methods. Gene targeting precisely alters a gene in its natural chromosome location, providing distinct advantages over gene-addition approaches. Classic gene-targeting delivery systems (microinjection, electroporation, or calcium phosphate transfection) have led to major scientific advances, but are too inefficient in their current state to be used for some applications, including gene therapy. This review describes the development of gene-targeting vectors based on three types of viruses (retrovirus, adenovirus, and adeno-associated virus) and discusses the design, possible mechanisms of action, and applications of gene-targeting vectors based on adeno-associated virus.

Entities:  

Mesh:

Year:  2005        PMID: 15932801     DOI: 10.1016/j.ymthe.2005.04.006

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  34 in total

Review 1.  Growth factor delivery for oral and periodontal tissue engineering.

Authors:  Darnell Kaigler; Joni A Cirelli; William V Giannobile
Journal:  Expert Opin Drug Deliv       Date:  2006-09       Impact factor: 6.648

Review 2.  Viral manipulation of DNA repair and cell cycle checkpoints.

Authors:  Mira S Chaurushiya; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2009-05-26

3.  An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells.

Authors:  Jae-Hyung Jang; James T Koerber; Jung-Suk Kim; Prashanth Asuri; Tandis Vazin; Melissa Bartel; Albert Keung; Inchan Kwon; Kook In Park; David V Schaffer
Journal:  Mol Ther       Date:  2011-01-11       Impact factor: 11.454

4.  Gene and stem cell therapy: alone or in combination?

Authors:  Mohammad A Rafi
Journal:  Bioimpacts       Date:  2011-12-09

Review 5.  Advances in targeted genome editing.

Authors:  Pablo Perez-Pinera; David G Ousterout; Charles A Gersbach
Journal:  Curr Opin Chem Biol       Date:  2012-07-20       Impact factor: 8.822

6.  Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors.

Authors:  Eva-Maria Händel; Katharina Gellhaus; Kafaitullah Khan; Christien Bednarski; Tatjana I Cornu; Felix Müller-Lerch; Robert M Kotin; Regine Heilbronn; Toni Cathomen
Journal:  Hum Gene Ther       Date:  2011-12-14       Impact factor: 5.695

7.  Competitive electroporation formulation for cell therapy.

Authors:  M Flanagan; J M Gimble; G Yu; X Wu; X Xia; J Hu; S Yao; S Li
Journal:  Cancer Gene Ther       Date:  2011-06-10       Impact factor: 5.987

8.  Ku70, an essential gene, modulates the frequency of rAAV-mediated gene targeting in human somatic cells.

Authors:  Farjana J Fattah; Natalie F Lichter; Kazi R Fattah; Sehyun Oh; Eric A Hendrickson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

Review 9.  Gene therapy of benign gynecological diseases.

Authors:  Memy H Hassan; Essam E Othman; Daniela Hornung; Ayman Al-Hendy
Journal:  Adv Drug Deliv Rev       Date:  2009-05-13       Impact factor: 15.470

10.  Engineering Large Animal Species to Model Human Diseases.

Authors:  Christopher S Rogers
Journal:  Curr Protoc Hum Genet       Date:  2016-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.